My Mum Had Breast Cancer at 42. What Are My Odds?

If your mother was diagnosed with breast cancer in her early forties, the honest version of the question "my mum had breast cancer, will I get it?" is really about numbers: how much does that actually shift my own risk, in figures I can hold onto? You deserve a real answer rather than a vague multiplier. So here it is up front. Having a mother diagnosed with breast cancer does raise your own risk above someone with no family history, and a diagnosis in her early forties counts for more than one at seventy would. But it is a shift on a baseline, not a sentence, and most women with one affected close relative never develop breast cancer.

The reason so much advice on this feels useless is that it gives you a relative risk with no denominator. "Twice the risk" means nothing until you know twice what. So this page does it the other way round. It starts with the absolute risk of breast cancer for women in the UK, then shows honestly how a mother's early diagnosis moves that number, and where that leaves you for screening and for cover.

The short answer: a real shift on a known baseline

Two facts have to sit next to each other for any of this to make sense. The first is that breast cancer is common, so it appears in a great many families by chance alone. The second is that a mother diagnosed in her early forties is exactly the kind of detail that does carry weight, because age at diagnosis is one of the things clinicians look at when they judge whether a family pattern is meaningful.

Both can be true at once. Your risk is higher than the population average, and it is still, for most women in your position, a risk rather than a likelihood. The job of this article is to keep those two things in proportion, because the danger is a frightened over-reaction in one direction or a dismissive shrug in the other, and neither serves you.

What actually decides where you land is the wider shape of your family, not the single fact of your mother's diagnosis. One relative, even a young one, is treated differently from several relatives, from cancers on both sides, from a relative with cancer in both breasts, or from breast and ovarian cancer appearing together. Those patterns are what push a family from near-population risk into a higher band.

The baseline: how common breast cancer already is

Start with the denominator, because every relative-risk figure you will read online is meaningless without it. Across a whole lifetime, roughly one in seven women in the UK is diagnosed with breast cancer. It is the most common cancer in women, and the great majority of those diagnoses are in women with no strong family history at all.

Source: Cancer Research UK, breast cancer incidence and lifetime risk statistics, drawing on national cancer registration data.

Hold that one-in-seven figure, because it does two useful things. It tells you that a breast cancer diagnosis in a family is common enough that a single case is often chance rather than a marching inherited fault. And it gives you the number that your mother's diagnosis adjusts. When someone quotes you a doubled or tripled risk, they are talking about moving this baseline, not conjuring a risk out of nowhere. A modest multiplier on a one-in-seven starting point is a very different thing from the catastrophe the phrasing implies.

It is worth being clear that this lifetime figure spans your whole life, and most breast cancer occurs later in life. Your risk in any given year in your thirties or forties is much lower than the lifetime headline suggests, which is the same denominator trap that catches people reading a single headline figure about a parent's stroke and applying it to themselves today.

What a mother diagnosed at 42 actually changes

Now the adjustment. A first-degree relative — a mother, sister or daughter — with breast cancer raises your own risk, and the younger she was at diagnosis, the more it is weighted. A diagnosis in the early forties is young enough to matter in that assessment, where a diagnosis in old age would barely move the needle.

But a single affected first-degree relative, on its own, usually keeps you closer to the general population than most people fear. What lifts risk into a higher category is a cluster: two or more close relatives affected, diagnoses at young ages, bilateral breast cancer, male breast cancer in the family, or breast and ovarian cancer together. If your mother's diagnosis is the only case you know of, you are more likely to be in the lower risk bands than the highest one.

The UK framework that turns this into something usable comes from NICE, which sorts family-history risk by estimated lifetime risk. Near-population risk sits below a seventeen per cent lifetime chance; moderate risk runs from seventeen per cent up to thirty per cent; high risk is thirty per cent or above, or where a high-risk gene fault is known in the family. These bands are what a GP or a family-history clinic uses to decide what happens next for you.

Source: National Institute for Health and Care Excellence, clinical guideline CG164, Familial breast cancer: classification, care and managing breast cancer risk in people with a family history.

The practical takeaway is that "how much does my mother's diagnosis raise my risk" is not answered by a single number, but by which band the whole picture puts you in. That is a conversation to have with a GP with the family details in front of you, not a figure to settle alone at two in the morning.

The number that moves survival most: stage at diagnosis

There is a second number that deserves more of your attention than the inherited-risk one, and it is the stage at which a breast cancer is found. Survival in England varies enormously by stage — that is, how far the cancer has spread by the time it is diagnosed. Caught at the earliest stage, when it is still contained, almost everyone survives at least five years. Found once it has spread to distant parts of the body, the proportion is far lower, and every stage in between sits on that slope.

Source: NHS England and the National Disease Registration Service, Cancer Survival in England, cancers diagnosed 2018 to 2022, published under the Open Government Licence v3.0.

That gradient is the reason a family history is worth taking seriously without letting it frighten you into paralysis. Its most useful role is not as a prophecy but as the thing that can get you screened earlier and more closely, which pushes the stage at diagnosis — if it ever comes to that — towards the survivable end. You cannot change the genes you were handed. You can change how early a problem is caught.

One honest caveat about those survival figures: they describe people who have already been diagnosed. They answer "given a breast cancer found at this stage, how many survive five years", not "what is my chance of ever getting breast cancer" and not "what is my chance of dying of it from where I stand today, cancer-free". Do not lift them straight onto yourself as a healthy woman. Your risk of ever being diagnosed is a separate, and for most women a much smaller, question.

Screening earlier than 50, and what triggers it

The routine NHS Breast Screening Programme invites women from the age of 50 up to their seventy-first birthday, offering a mammogram every three years. That is built for the general population and takes no account of family history on its own.

Where a family history meets the NICE criteria, the picture changes. A GP can refer you to a breast clinic or a family-history service, which will assess your risk band and, for moderate or high risk, may arrange earlier or more frequent surveillance — often annual mammograms starting in your forties, sometimes with MRI for the highest-risk group. This is not something you have to argue for from a position of no information; it is a defined pathway, and your mother's age at diagnosis is precisely the kind of detail that helps a clinician place you correctly.

Before that appointment, gather what you can: which relatives were affected, on which side of the family, at what ages, and whether any had ovarian cancer or cancer in both breasts. You can read how the NHS approaches family history and referral on the NHS breast cancer pages. If your mother is currently unwell rather than years past treatment, there is a separate and more immediate set of practical tasks, which we set out in the papers to find this week when a parent has terminal cancer.

Your family history on a life insurance form

Two worries usually arrive together here: the health worry and the insurance worry. On the insurance side, the position is more protective than most people expect, and it is worth knowing before you fill anything in.

A predictive genetic result — a BRCA1 or BRCA2 test that tells you about future risk before any disease — cannot be asked for or used on a UK life insurance application under the industry Code agreed between government and insurers. Insurance should therefore not be the thing that drives your decision about whether to have a BRCA test; that is a decision to make with a genetics service, ideally starting with an affected relative. What the line between a protected predictive result and an ordinary disclosable one looks like in practice is worked through in ten worked UK examples of predictive versus diagnostic results.

What insurers can still ask about is your family history in the ordinary sense, and your own medical history. Family history is a fair question on a form, and answering it accurately — your mother's diagnosis, her age at it, any other affected relatives — is part of taking reasonable care. It rarely carries the weight people fear, and different insurers weigh the same answer differently, which is exactly why comparing matters. Newer tools that estimate risk from many small genetic variations at once sit in a genuinely unsettled corner of the rules, which we cover in whether a polygenic risk score counts as a genetic test.

For most readers of this page the situation is straightforward: a family history, no diagnosis of your own, and people who depend on you. You can get life insurance quotes and let an FCA-authorised broker place your particular history sensibly rather than assume a family history rules cover out. The wider picture of how family history sits within an application is gathered in our guide to family history, inherited risk and the odds.

Scotland, Northern Ireland and where to check

The clinical framework for familial breast cancer is broadly consistent across the UK, but breast screening is run separately by each nation, and the referral routes into genetics and earlier surveillance are organised nation by nation. Scotland, Wales and Northern Ireland each run their own screening programmes on their own timetables, so the exact age band and the way you are referred for a family-history assessment can differ from England. If you live outside England, check what applies locally rather than assuming the age and the pathway are identical.

The insurance position, by contrast, does not vary by nation: the Code that keeps a predictive genetic result off your application is a UK-wide agreement and applies wherever you live. What differs across the UK is the statutory route for seeing and correcting the medical report an insurer may request from your GP, which follows a different law in Northern Ireland, where a 1991 Order applies rather than the Act used in the rest of the UK. Wherever you are, the underlying message holds: start from the baseline, let a clinician place your family history in the right band, and treat earlier screening — not fear — as the useful response.

Frequently asked questions

How much does my mother's breast cancer raise my risk?

Having a mother diagnosed with breast cancer increases your own risk relative to someone with no family history, and a diagnosis in her early forties carries more weight than one at seventy. It is a shift in odds on a baseline of roughly one in seven women, not a certainty, and most women with one affected relative do not develop breast cancer. Where the whole family picture lands you depends on how many relatives were affected and at what ages.

Will I be offered screening earlier than 50?

The routine NHS breast screening programme invites women from 50 up to their seventy-first birthday. Where a family history meets NICE criteria, a GP can refer you for assessment, and earlier or more frequent surveillance may then be arranged through a breast clinic or genetics service rather than the routine programme. Bring the ages and relationships of affected relatives to that appointment, as they help decide which risk band you are in.

Should I have a BRCA test?

That is a decision made with a genetics service rather than alone. Testing is usually offered where the family pattern suggests an inherited fault, and it ideally starts with an affected relative. Insurance should not sway it, because a predictive BRCA result cannot be asked for on a UK life application, so having the test does not disadvantage a future application for the result itself.